查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球褐藻醣膠市場 - 2023-2030
市場調查報告書
商品編碼
1359941

全球褐藻醣膠市場 - 2023-2030

Global Fucoidan Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述 ：

2022年，全球褐藻醣膠市場規模達9,050萬美元，預估至2030年將達2.026億美元，2023-2030年預測期間複合年成長率為10.6%。

由於對天然保健品和原料的需求不斷成長，褐藻醣膠市場最近不斷擴大。褐藻醣膠通常作為膠囊或粉末形式的補充劑用於多種食品和飲料中。岩藻依聚醣市場受到多種因素的影響，包括對有機產品的需求不斷成長、健康意識的提高以及慢性病的增加。褐藻醣膠在治療免疫失調、癌症和心血管疾病方面具有許多潛在優勢。

隨著製藥業的發展，全球對岩藻依聚醣的需求不斷增加。抗氧化劑使用的是岩藻依聚醣。它也用作抗腫瘤劑、抗血管生成劑、抗病毒劑、抗發炎劑、抗凝血劑和抗血栓劑。護膚品和化妝品產業也擴大使用岩藻依聚醣。它具有許多保持皮膚彈性和保水性的有利品質。

對於開發新的化妝品配方，例如抗衰老護膚品，岩藻依聚醣是目前正在研究的天然替代品。例如，2023年5月，英國公司OCEANIUM創造了高純度生物活性成分“OCEAN ACTIVES Fucoidan”，化妝品公司可以用它來創造各種護膚配方。與此類似，Luminact Brite 和 Luminact Reverse 是由岩藻依聚醣成分供應商 Marinova 與總部位於德國的特種化學品製造商 Innospec 合作開發的化妝品成分。

動態：

不斷努力改進微藻萃取和培養

營養食品和補充品市場對源自藻類的岩藻依聚醣的需求不斷增加。與其他 BETA-葡聚醣（例如酵母來源的 BETA-葡聚醣）相比，藻類 BETA-葡聚醣更便宜。此外，幾種棕色海藻主要在細胞壁基質上含有岩藻依聚醣。來自微藻的BETA-葡聚醣和岩藻依聚醣萃取物目前是廣泛研究的主題。由於這個因素，市場正在擴大。透過提高生產能力，微藻原料供應商不斷努力滿足岩藻依聚醣市場客戶的需求。

例如，美國生物技術公司F3 Platform Biologics 於2019 年8 月向Algatech Ltd. 授予從微藻眼蟲中生產Beta-1 和Beta-3 葡聚醣的許可和權利。此外，透過開發微藻培養的萃取方法，生產商將能夠在食品、膳食補充劑和醫療保健等多種行業中成功使用 BETA-葡聚醣微藻。許多組織正在這方面做出大量努力。預計這些因素將很快支持整個市場的擴張。

全球心血管疾病和癌症病例正在增加

在已開發國家，心臟病和中風在成人死亡人數中排名第一和第二。為了在迫切需要治療之前幫助預防，對促進心血管健康和抑制癌細胞的膳食補充劑和營養保健品的需求增加。值得注意的是，已經證明岩藻依聚醣和BETA-葡聚醣可以安全有效地治療這兩種疾病。 BETA-葡聚醣和岩藻依聚醣有助於動員免疫細胞並啟動防禦反應。在癌症的情況下，這種觸發的反應有助於身體計劃對癌細胞的協調攻擊。此外，它還有助於抑制癌細胞的生長。這些因素支持市場擴張。

生產成本高

從海藻中提取褐藻醣膠可能非常昂貴且需要大量勞動力。這可能會影響岩藻依聚醣產品的可承受性和市場滲透率。含有岩藻依聚醣的特定海藻種類可能很難找到，並且需要大量勞動力才能採集。海藻收穫需要船隻、熟練勞動力和設備。此外，富含岩藻依聚醣的海藻的獲取可能因地區和季節而異。

為了確保岩藻依聚醣的品質和純度，需要嚴格的品質控管程序。其中包括污染物測試，確保不含重金屬或其他污染物，以及檢查岩藻依聚醣的含量。此外，從海藻中提取岩藻依聚醣需要複雜且漫長的程序。這通常需要使用各種方法和溶劑進行清潔、乾燥、研磨和提取岩藻依聚醣。這些過程需要熟練的勞動力和專用機械。預計這些因素將在一定程度上限制市場擴張。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按表格列出的片段
  • 按功能分類的片段
  • 按應用程式片段
  • 按地區分類的片段

第 4 章：動力學

  • 影響因素
    • 動力
      • 不斷努力改進微藻萃取和培養
      • 全球心血管疾病和癌症病例正在增加
    • 限制
      • 生產成本高
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 俄烏戰爭影響分析
  • DMI 意見

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按類型

  • 粉末
  • 膠囊
  • 其他

第 8 章：依功能分類

  • 免疫力增強劑
  • 心血管健康
  • 其他

第 9 章：按應用

  • 食品和飲料
  • 補充品
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • KANEHIDE BIO Co., Ltd.
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Kamerycah, Inc.
  • Yaizu Suisankagaku
  • Fucoidan Force
  • Seaherb
  • Haerim Fucoidan
  • Marinova
  • Hi-Q Marine Biotech International Ltd.
  • Molekula Group
  • Absonutrix LLC LIST NOT EXHAUSTIVE

第 13 章：附錄

簡介目錄
Product Code: FB6992

Overview:

Global Fucoidan Market reached US$ 90.5 million in 2022 and is expected to reach US$ 202.6 million by 2030, growing with a CAGR of 10.6% during the forecast period 2023-2030.

Due to the rising demand for natural health products and ingredients, the fucoidan market has expanded recently. Fucoidan is commonly utilized in a range of foods and beverages often available, as supplements in the form of capsules or powders. The market for fucoidan is being influenced by factors, including the growing demand for organic products increasing health awareness and the rise, in chronic diseases. Fucoidan has a number of potential advantages in the treatment of immune disorders, cancer, and cardiovascular disease.

Global demand for fucoidan is increasing as the pharmaceutical sector grows. Antioxidant use is made of fucoidan. It is also employed as an antitumor, anti-angiogenic, antiviral, anti-inflammatory, anticoagulant, and antithrombotic agent. The skincare and cosmetics industries are also using more and more fucoidan. It has a number of advantageous qualities for maintaining skin elasticity and water retention.

For the development of new cosmetic product formulations, such as anti-aging skin care products, fucoidan is a natural alternative that is currently being researched. For instance, in May 2023, the U.K. company OCEANIUM created the high-purity bioactive ingredient 'OCEAN ACTIVES Fucoidan,' which cosmetic companies can use to create various skincare formulations. Similar to this, Luminact Brite and Luminact Reverse are cosmetic ingredients that were developed by Marinova, a supplier of fucoidan ingredients, in collaboration with Innospec, a manufacturer of specialty chemicals with headquarters in Germany.

Dynamics:

Growing Efforts to Improve Microalgae Extraction and Cultivation

The market for nutritional food and supplements is seeing an increase in demand for fucoidans derived from algae. Compared to other beta-glucans, such as yeast-derived beta-glucan, the algal beta-glucan is less expensive. Moreover, several species of brown seaweed contain fucoidan primarily on the cell wall matrix. Beta-glucan and fucoidan extracts from microalgae are currently the subject of extensive research. The market is expanding as a result of this factor. By improving their production capabilities, the suppliers of microalgae ingredients are continuously working to meet the demands of customers in the fucoidan market.

For instance, the US biotechnology company F3 Platform Biologics granted the licence and the rights to produce Beta-1 and Beta-3 glucans from the microalgae Euglena Gracilis to Algatech Ltd. in August 2019. Additionally, by developing extraction methods for microalgae cultivation, producers will be able to use beta-glucan microalgae successfully in a variety of industries, including food, dietary supplements, and healthcare. Numerous organisations are making numerous efforts in this regard. These factors are anticipated to soon support the market's expansion as a whole.

Global Cardiovascular Disease and Cancer Cases are Growing

In developed countries, heart disease and stroke are first and second in terms of adult fatalities. To help with prevention before an urgent need for a cure arises, demand for dietary supplements and nutraceuticals that boost cardiovascular health and inhibit cancer cells has increased. Notably, it has been proven that fucoidans and beta-glucans can be used to treat both diseases in a safe and effective manner. Beta-glucans and fucoidans assist in mobilising immune cells and initiating a defence response. In cases of cancer, this triggered response helps the body plan a coordinated attack on cancer cells. Additionally, it helps to restrain the growth of cancerous cells. These factors support market expansion.

High Production Costs

Fucoidan can be expensive and labor-intensive to extract from seaweed. This may have an impact on fucoidan product affordability and market penetration. The specific kinds of seaweed that contain fucoidan can be difficult to find and require a lot of labour to gather. Boats, skilled labour, and equipment are needed for seaweed harvesting. Furthermore, the accessibility of seaweed abundant in fucoidan may differ regionally and according to the season.

Strict quality control procedures are required in order to guarantee the fucoidan's quality and purity. Testing for contaminants, making sure there are no heavy metals or other pollutants, and checking the amount of fucoidan are all included in this. Moreover, complicated and drawn-out procedures are needed to extract fucoidan from seaweed. This typically entails cleaning, drying, grinding, and extracting fucoidan using a variety of methods and solvents. Both skilled labour and specialised machinery are needed for these processes. Such elements are anticipated to limit market expansion to some degree.

Segment Analysis:

The global fucoidan market is segmented based on form, functionality, application and region.

Capsule Form can be Used for Producing Pharmaceuticals and Dietary Supplements

The capsule segment leads the market. The capsule has a higher bioavailability than other forms, such as liquid, semi-liquid, or powder form. This qualifies it as an appropriate delivery method that enables the compound to be effectively delivered to the bloodstream. These attributes make the product well suited for manufacturing top notch medications for individuals dealing with conditions such, as cancer diabetes, Alzheimers disease (AD) and ailments. Furthermore several companies are introducing supplements, in format as they are easier to ingest and mask the unfavorable tastes and smells associated with their components.

Geographical Penetration:

Rising Prevalence of Health Ailments and Life-Threatening Diseases is Driving the Demand for Market in Europe

The growing demand, for compound-based pharmaceuticals in the region has been fueled by an emphasis on discovering ingredients for developing innovative medications and dietary supplements through clinical trials. The U.K. market in comparison to countries is also experiencing growth. Many startups are expanding their capabilities to process seaweed, which is expected to drive market expansion. The use of seaweed and seaweed processing in this country is growing, even though humans consume a significant amount of seaweed. Producing high-end, premium products that can be used in pharmaceuticals, cosmetics, and dietary supplements is where manufacturers focus their efforts.

COVID-19 Impact Analysis:

The COVID-19 pandemic had an impact on the availability of the raw material (brown seaweed), which is processed to further develop fucoidan. Many farmers in Europe and Asia, two of the top seaweed exporters, were unable to harvest seaweed in a timely manner, which led to the decay of the seaweed and financial loss for the concerned farmers. During the COVID-19 pandemic, its use in the pharmaceutical industry was also impacted. Some of the areas that suffered a great deal during that time were clinical trials and research. Clinical trials of new products on patients were severely hampered as hospital visits by diabetics, cancer patients, and other patients decreased out of contracting for catching COVID-19.

Russia-Ukraine War Impact Analysis:

When a supply chain depends on resources or infrastructure in areas where there is conflict, such as when harvesting seaweed or using extraction facilities or transportation routes, disruptions could happen. This could result in scarcities and higher production costs. Geopolitical tensions can affect the price of imports and exports by causing currency fluctuations. Currency devaluation in either country increased the marketability of their products, which had an impact on fucoidan prices.

By Form

  • Powder
  • Capsule
  • Others

By Functionality

  • Immunity Booster
  • Cardiovascular Health
  • Others

By Application

  • Food and Beverages
  • Supplements
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In May, 2023, a high-purity bioactive ingredient called "OCEAN ACTIVES Fucoidan" was created by the U.K. company OCEANIUM that cosmetic companies can use to create various skincare formulations.
  • In April, 2023, Official support for the Royal Society of Chemistry spring meeting came from Dextra Laboratories Ltd. The conference would provide funding for the ECR bursaries, enhancing the participation of young researchers.
  • In February, 2023, Hepatica made significant investments to build its production system in accordance with the standards set by the European Commission. The company's production, supply, and storage systems were awarded the HACCP certificate.

Competitive Landscape

The major global players in the market: KANEHIDE BIO Co., Ltd, Kamerycah, Inc., Yaizu Suisankagaku, Fucoidan Force, Seaherb, Haerim Fucoidan, Marinova, Hi-Q Marine Biotech International Ltd., Molekula Group, and Absonutrix LLC.

Why Purchase the Report?

  • To visualize the global fucoidan market segmentation based on form, functionality, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of fucoidan market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global fucoidan market report would provide approximately 61 tables, 56 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Form
  • 3.2. Snippet by Functionality
  • 3.3. Snippet by Application
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Efforts to Improve Microalgae Extraction and Cultivation
      • 4.1.1.2. Global Cardiovascular Disease and Cancer Cases are Growing
    • 4.1.2. Restraints
      • 4.1.2.1. High Production Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Powder*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Capsule
  • 7.4. Others

8. By Functionality

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 8.1.2. Market Attractiveness Index, By Functionality
  • 8.2. Immunity Booster*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cardiovascular Health
  • 8.4. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Food and Beverages*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Supplements
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Functionality
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. KANEHIDE BIO Co., Ltd.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Kamerycah, Inc.
  • 12.3. Yaizu Suisankagaku
  • 12.4. Fucoidan Force
  • 12.5. Seaherb
  • 12.6. Haerim Fucoidan
  • 12.7. Marinova
  • 12.8. Hi-Q Marine Biotech International Ltd.
  • 12.9. Molekula Group
  • 12.10. Absonutrix LLC LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us